Dr. Ewa Konopka, DDS Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 21038 Calistoga St., Middletown, CA 95461 Phone: 707-987-2773 Fax: 707-987-0688 |
Sheila Safarian, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 21128 Calistoga Road, #0123, Middletown, CA 95461 Phone: 707-987-3307 Fax: 707-987-3318 |
Paul Howard Nielsen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 20591 Honey Hill Dr, Middletown, CA 95467 Phone: 707-987-3712 |
Dr. Ian P. Van Zyl, DDS, MS Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 21038 Calistoga St., Middletown, CA 95461 Phone: 707-987-2773 Fax: 707-987-0688 |
News Archive
A study that investigated the potential of the compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis (scarring) in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.
Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent.
Scientists have long searched in vain for a class of brain cells that could explain the visceral flash of recognition that we feel when we see a very familiar face, like that of our grandmothers.
Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.
When a receptionist hands out a form to fill out at a doctor's office, the questions are usually about medical issues: What's the visit for? Are you allergic to anything? Up to date on vaccines?
› Verified 3 days ago